subscribeSubscribe
price-trendAsk Us
UK MHRA grants Mkt approval for ViiV`s cabotegravir formulations prevent HIV-1

UK MHRA grants Mkt approval for ViiV`s cabotegravir formulations prevent HIV-1
PHARMABIZ
04 May 2024
Share Share
FDA approves first extended-release injectable, complete regimen for HIV

FDA approves first extended-release injectable, complete regimen for HIV
EUROPEANPHARMACEUTICALREVIEW
22 Jan 2021
Share Share
GSK`s ViiV nabs first approval for HIV game-changer Cabenuva

GSK`s ViiV nabs first approval for HIV game-changer Cabenuva
K. Blankenship FIERCE PHARMA
21 Mar 2020
Share Share
Positive Recommendation by NICE for first anti-CGRP migraine therap

Positive Recommendation by NICE for first anti-CGRP migraine therap
BUSINESSWIRE
12 Mar 2020
Share Share
FDA slams GSK`s monthly HIV injectable with CRL, citing manufacturing issues

FDA slams GSK`s monthly HIV injectable with CRL, citing manufacturing issues
Amber Tong ENDPTS
24 Dec 2019
Share Share
ViiV inks bNAb deal with National Institutes of Health

ViiV inks bNAb deal with National Institutes of Health
Anna Smith PHARMA TIMES
22 Nov 2019
Share Share